Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1995 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 6,393 |
| Marketable Securities | 12,303 |
| Receivables | 1,000 |
| Other current assets | 234 |
| TOTAL | $19,930 |
| Non-Current Assets | |
| PPE Net | 2,773 |
| Other Non-Current Assets | 1,308 |
| TOTAL | $4,081 |
| Total Assets | $24,011 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 821 |
| Accrued Expenses | 879 |
| Other current liabilities | 500 |
| TOTAL | $2,941 |
| Non-Current Liabilities | |
| TOTAL | $1,845 |
| Total Liabilities | $4,786 |
| Shareholders' Equity | |
| Common Shares | 35,598 |
| Retained earnings | -15,895 |
| Other shareholders' equity | -478 |
| TOTAL | $19,225 |
| Total Liabilities And Equity | $24,011 |